Purpose
Idoven is dedicated to applying artificial intelligence to cardiology, providing clinicians with ECG interpretation and cardiovascular disease detection capabilities to support early detection and precision medicine. Its platform is positioned as "cardiology-as-a-service," aiming to enhance clinicians' ability to identify, triage, and diagnose patients at scale.
Key Capabilities
- Automatically detects 23 unique cardiac patterns, enabling rapid and accurate identification of cardiac abnormalities such as arrhythmias.
- Reduces the time and cost required for ECG interpretation.
- Can be seamlessly integrated into home monitoring systems and electronic health record (EHR) systems for large-scale patient triage and diagnosis.
- For the life sciences sector, it uses ECG-based biomarkers to develop disease risk scores, helping identify high-risk, undiagnosed, or undertreated patients, assisting in predicting potential cardiovascular disease, and monitoring cardiac drug safety.
- Provides preventive screening programs, using non-invasive devices for continuous remote ECG monitoring, with proprietary algorithms and cardiologists analyzing the data and issuing medical-grade reports.
How to Use
Willem is Idoven's ECG analysis platform and has obtained Class IIa medical device certification (CE marking, compliant with EU MDR). The platform is based on cloud infrastructure and offers reliability, compliance, and security; it supports device neutrality and interoperability, can read data in standard and proprietary formats, can analyze ECGs of any duration and provide results within minutes, and is suitable for any ECG device compliant with IEC 60601-2-25, IEC 60601-2-27, and IEC 60601-2-47 standards. Specific access and usage steps are not yet provided.
Applicable Scenarios
- Medical institutions: large-scale ECG interpretation, triage, and diagnosis.
- Life sciences companies: developing disease risk scores, predicting cardiovascular disease, monitoring cardiac drug safety.
- Organizational health management: providing employees with preventive screening and continuous remote ECG monitoring.
- Individuals participating in research: synchronizing Apple Watch and anonymously sharing ECG through the "Donate Your Heartbeats" app to participate in heart disease research.
Limitations and Notes
The platform states that it uses a manually annotated ECG database for AI training, and collaborates with multiple research centers and industry partners in Europe and the United States on clinical research (such as the MAESTRIA H2020 project for stroke and atrial fibrillation), with publications in top scientific journals, and currently hasmultiple cardiovascular disease prediction models under development. Idoven collaborates with clinical partners in more than 20 countries on clinical research, research consortia, and real-world deployments. However, the source material does not provide specific pricing methods, prices, detailed deployment conditions, or complete clinical performance data.